Seminar
Wednesday 21st February 2024
Accelerating clinical dosage form development.
Babraham Research Campus, Cambridge
1pm – 5pm
This event is fully booked. Contact us to ask about our upcoming events.
This seminar will explore relevant solutions for accelerating nasal and oral clinical dosage form development.
Hosted by Dr Richard Johnson, Chief Scientific Officer at UK-based CDMO, Upperton Pharma Solutions, this seminar will cover formulation platforms, analytical characterisation techniques, and different particle engineering strategies to enhance drug success rates.
Key learning objectives
- Gain insights on strategies for reducing risks during nasal and oral clinical formulation development.
- Review drug product options for early clinical evaluation.
- Understand the potential advantages of spray drying to address solubility or particle engineering challenges.
- Network with other professionals.
- Speak with our experts during an interactive Q&A session.
Who should attend
- Pharmaceutical researchers and scientists.
- CMC experts on inhalation/nasal and oral drug delivery.
- Nasal and oral product development professionals.
Meet our experts
Dr Richard Johnson
Chief Scientific Officer and Founder, Upperton Pharma Solutions
Ian Lafferty
Chief Technical Officer,
Upperton Pharma Solutions
Location
King Hedges Room,
Babraham Research Campus,
Cambridge,
CB22 3AT.
Book your place
Register below to book your place at our Cambridge seminar. A member of our team will be in touch.